Skip to content

For a Better Interpretation of Quality of Life Scores of Kidney Transplant Patients: Determination of the Minimum Significant Change RetransQol

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02870374
Acronym
ReTransQol
Enrollment
2000
Registered
2016-08-17
Start date
2012-01-31
Completion date
2017-01-31
Last updated
2016-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidneys Transplantation

Brief summary

The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans. The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol

Interventions

BEHAVIORALAnswering specific quality of life questionnaire in kidneys transplantation population

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a transplant kidney

Exclusion criteria

* Patient not able to answer survey

Design outcomes

Primary

MeasureTime frame
Number of change in quality of life in kidneys transplantation patients using ReTransQol1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026